As cell therapy advances toward clinical reality, iPSC-derived cellular products, in vivo reprogramming strategies, and manufacturing-ready reagent platforms are reshaping regenerative medicine and ...
AI and multimodal data are driving a shift toward N-of-1 medicine, tailoring interventions to a person's unique biological ...
Scientists are exploring DNA-based robots, tiny molecular machines that could one day navigate the body, deliver targeted therapies, and even build nanoscale technologies.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results